Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

TherapeuticsMD Company Profile (NASDAQ:TXMD)

Consensus Ratings for TherapeuticsMD (NASDAQ:TXMD) (?)
Ratings Breakdown: 6 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $14.00 (198.51% upside)

Analysts' Ratings History for TherapeuticsMD (NASDAQ:TXMD)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/7/2014FBR Capital MarketsInitiated CoverageOutperform$34.00ViewTweet This Rating  Share This Rating on StockTwits
6/18/2014Noble FinancialReiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
6/17/2014JMP SecuritiesInitiated CoverageOutperform$7.00ViewTweet This Rating  Share This Rating on StockTwits
5/29/2014Jefferies GroupInitiated CoverageBuy$7.00ViewTweet This Rating  Share This Rating on StockTwits
4/17/2014Noble FinancialBoost Price TargetBuy$9.00 -> $13.00ViewTweet This Rating  Share This Rating on StockTwits
1/28/2014Noble FinancialReiterated RatingBuy$7.25 -> $9.00ViewTweet This Rating  Share This Rating on StockTwits
1/10/2014Noble FinancialReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
1/8/2014Cowen and CompanyInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
11/1/2013Stifel NicolausInitiated CoverageBuy$8.00ViewTweet This Rating  Share This Rating on StockTwits
4/26/2013Jefferies GroupInitiated CoverageBuy$4.00ViewTweet This Rating  Share This Rating on StockTwits
4/24/2013Noble FinancialInitiated CoverageBuy$5.50ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/24/2012 forward)